377 related articles for article (PubMed ID: 35682369)
1. Harmonization of Human Biomonitoring Studies in Europe: Characteristics of the HBM4EU-Aligned Studies Participants.
Gilles L; Govarts E; Rodriguez Martin L; Andersson AM; Appenzeller BMR; Barbone F; Castaño A; Coertjens D; Den Hond E; Dzhedzheia V; Eržen I; López ME; Fábelová L; Fillol C; Franken C; Frederiksen H; Gabriel C; Haug LS; Horvat M; Halldórsson TI; Janasik B; Holcer NJ; Kakucs R; Karakitsios S; Katsonouri A; Klánová J; Kold-Jensen T; Kolossa-Gehring M; Konstantinou C; Koponen J; Lignell S; Lindroos AK; Makris KC; Mazej D; Morrens B; Murínová ĽP; Namorado S; Pedraza-Diaz S; Peisker J; Probst-Hensch N; Rambaud L; Rosolen V; Rucic E; Rüther M; Sarigiannis D; Tratnik JS; Standaert A; Stewart L; Szigeti T; Thomsen C; Tolonen H; Eiríksdóttir Á; Van Nieuwenhuyse A; Verheyen VJ; Vlaanderen J; Vogel N; Wasowicz W; Weber T; Zock JP; Sepai O; Schoeters G
Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682369
[TBL] [Abstract][Full Text] [Related]
2. Harmonized human biomonitoring in European children, teenagers and adults: EU-wide exposure data of 11 chemical substance groups from the HBM4EU Aligned Studies (2014-2021).
Govarts E; Gilles L; Rodriguez Martin L; Santonen T; Apel P; Alvito P; Anastasi E; Andersen HR; Andersson AM; Andryskova L; Antignac JP; Appenzeller B; Barbone F; Barnett-Itzhaki Z; Barouki R; Berman T; Bil W; Borges T; Buekers J; Cañas-Portilla A; Covaci A; Csako Z; Den Hond E; Dvorakova D; Fabelova L; Fletcher T; Frederiksen H; Gabriel C; Ganzleben C; Göen T; Halldorsson TI; Haug LS; Horvat M; Huuskonen P; Imboden M; Jagodic Hudobivnik M; Janasik B; Janev Holcer N; Karakitsios S; Katsonouri A; Klanova J; Kokaraki V; Kold Jensen T; Koponen J; Laeremans M; Laguzzi F; Lange R; Lemke N; Lignell S; Lindroos AK; Lobo Vicente J; Luijten M; Makris KC; Mazej D; Melymuk L; Meslin M; Mol H; Montazeri P; Murawski A; Namorado S; Niemann L; Nübler S; Nunes B; Olafsdottir K; Palkovicova Murinova L; Papaioannou N; Pedraza-Diaz S; Piler P; Plichta V; Poteser M; Probst-Hensch N; Rambaud L; Rauscher-Gabernig E; Rausova K; Remy S; Riou M; Rosolen V; Rousselle C; Rüther M; Sarigiannis D; Silva MJ; Šlejkovec Z; Snoj Tratnik J; Stajnko A; Szigeti T; Tarazona JV; Thomsen C; Tkalec Ž; Tolonen H; Trnovec T; Uhl M; Van Nieuwenhuyse A; Vasco E; Verheyen VJ; Viegas S; Vinggaard AM; Vogel N; Vorkamp K; Wasowicz W; Weber T; Wimmerova S; Woutersen M; Zimmermann P; Zvonar M; Koch H; Kolossa-Gehring M; Esteban López M; Castaño A; Stewart L; Sepai O; Schoeters G
Int J Hyg Environ Health; 2023 Apr; 249():114119. PubMed ID: 36773580
[TBL] [Abstract][Full Text] [Related]
3. HBM4EU combines and harmonises human biomonitoring data across the EU, building on existing capacity - The HBM4EU survey.
Gilles L; Govarts E; Rambaud L; Vogel N; Castaño A; Esteban López M; Rodriguez Martin L; Koppen G; Remy S; Vrijheid M; Montazeri P; Birks L; Sepai O; Stewart L; Fiddicke U; Loots I; Knudsen LE; Kolossa-Gehring M; Schoeters G
Int J Hyg Environ Health; 2021 Aug; 237():113809. PubMed ID: 34455198
[TBL] [Abstract][Full Text] [Related]
4. Phthalates and substitute plasticizers: Main achievements from the European human biomonitoring initiative HBM4EU.
Gerofke A; Lange R; Vogel N; Schmidt P; Weber T; David M; Frederiksen H; Baken K; Govarts E; Gilles L; Martin LR; Martinsone Ž; Santonen T; Schoeters G; Scheringer M; Domínguez-Romero E; López ME; Calvo AC; Koch HM; Apel P; Kolossa-Gehring M
Int J Hyg Environ Health; 2024 Jun; 259():114378. PubMed ID: 38631089
[TBL] [Abstract][Full Text] [Related]
5. PFASs: What can we learn from the European Human Biomonitoring Initiative HBM4EU.
Uhl M; Schoeters G; Govarts E; Bil W; Fletcher T; Haug LS; Hoogenboom R; Gundacker C; Trier X; Fernandez MF; Calvo AC; López ME; Coertjens D; Santonen T; Murínová ĽP; Richterová D; Brouwere K; Hauzenberger I; Kolossa-Gehring M; Halldórsson ÞI
Int J Hyg Environ Health; 2023 May; 250():114168. PubMed ID: 37068413
[TBL] [Abstract][Full Text] [Related]
6. Human biomonitoring initiative (HBM4EU) - Strategy to derive human biomonitoring guidance values (HBM-GVs) for health risk assessment.
Apel P; Rousselle C; Lange R; Sissoko F; Kolossa-Gehring M; Ougier E
Int J Hyg Environ Health; 2020 Sep; 230():113622. PubMed ID: 33045523
[TBL] [Abstract][Full Text] [Related]
7. Development of Policy Relevant Human Biomonitoring Indicators for Chemical Exposure in the European Population.
Buekers J; David M; Koppen G; Bessems J; Scheringer M; Lebret E; Sarigiannis D; Kolossa-Gehring M; Berglund M; Schoeters G; Trier X
Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30248963
[TBL] [Abstract][Full Text] [Related]
8. The European Human Biomonitoring Initiative (HBM4EU): Human biomonitoring guidance values for selected phthalates and a substitute plasticizer.
Lange R; Apel P; Rousselle C; Charles S; Sissoko F; Kolossa-Gehring M; Ougier E
Int J Hyg Environ Health; 2021 May; 234():113722. PubMed ID: 33711757
[TBL] [Abstract][Full Text] [Related]
9. HBM4EU feasibility studies: Lessons learned in combining health and human biomonitoring studies.
Elonheimo HM; Uusitalo K; Moore S; Andersson AM; Baber R; Wirkner K; David M; Kolossa-Gehring M; Stewart L; Sepai O; Lermen D; Bartel-Steinbach M; Rantakokko P; Koponen J; Tolonen H
Int J Hyg Environ Health; 2023 Mar; 248():114100. PubMed ID: 36508963
[TBL] [Abstract][Full Text] [Related]
10. [Human Biomonitoring for Europe (HBM4EU)-first insights into the results of the initiative].
Weise P; Apel P; Kolossa-Gehring M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Sep; 65(9):936-939. PubMed ID: 35997778
[TBL] [Abstract][Full Text] [Related]
11. Current exposure to phthalates and DINCH in European children and adolescents - Results from the HBM4EU Aligned Studies 2014 to 2021.
Vogel N; Schmidt P; Lange R; Gerofke A; Sakhi AK; Haug LS; Jensen TK; Frederiksen H; Szigeti T; Csákó Z; Murinova LP; Sidlovska M; Janasik B; Wasowicz W; Tratnik JS; Mazej D; Gabriel C; Karakitsios S; Barbone F; Rosolen V; Rambaud L; Riou M; Murawski A; Leseman D; Koppen G; Covaci A; Lignell S; Lindroos AK; Zvonar M; Andryskova L; Fabelova L; Richterova D; Horvat M; Kosjek T; Sarigiannis D; Maroulis M; Pedraza-Diaz S; Cañas A; Verheyen VJ; Bastiaensen M; Gilles L; Schoeters G; Esteban-López M; Castaño A; Govarts E; Koch HM; Kolossa-Gehring M
Int J Hyg Environ Health; 2023 Apr; 249():114101. PubMed ID: 36805185
[TBL] [Abstract][Full Text] [Related]
12. Time Patterns in Internal Human Exposure Data to Bisphenols, Phthalates, DINCH, Organophosphate Flame Retardants, Cadmium and Polyaromatic Hydrocarbons in Europe.
Rodriguez Martin L; Gilles L; Helte E; Åkesson A; Tägt J; Covaci A; Sakhi AK; Van Nieuwenhuyse A; Katsonouri A; Andersson AM; Gutleb AC; Janasik B; Appenzeller B; Gabriel C; Thomsen C; Mazej D; Sarigiannis D; Anastasi E; Barbone F; Tolonen H; Frederiksen H; Klanova J; Koponen J; Tratnik JS; Pack K; Gudrun K; Ólafsdóttir K; Knudsen LE; Rambaud L; Strumylaite L; Murinova LP; Fabelova L; Riou M; Berglund M; Szabados M; Imboden M; Laeremans M; Eštóková M; Janev Holcer N; Probst-Hensch N; Vodrazkova N; Vogel N; Piler P; Schmidt P; Lange R; Namorado S; Kozepesy S; Szigeti T; Halldorsson TI; Weber T; Jensen TK; Rosolen V; Puklova V; Wasowicz W; Sepai O; Stewart L; Kolossa-Gehring M; Esteban-López M; Castaño A; Bessems J; Schoeters G; Govarts E
Toxics; 2023 Sep; 11(10):. PubMed ID: 37888670
[TBL] [Abstract][Full Text] [Related]
13. Human biomonitoring in health risk assessment in Europe: Current practices and recommendations for the future.
Louro H; Heinälä M; Bessems J; Buekers J; Vermeire T; Woutersen M; van Engelen J; Borges T; Rousselle C; Ougier E; Alvito P; Martins C; Assunção R; Silva MJ; Pronk A; Schaddelee-Scholten B; Del Carmen Gonzalez M; de Alba M; Castaño A; Viegas S; Humar-Juric T; Kononenko L; Lampen A; Vinggaard AM; Schoeters G; Kolossa-Gehring M; Santonen T
Int J Hyg Environ Health; 2019 Jun; 222(5):727-737. PubMed ID: 31176761
[TBL] [Abstract][Full Text] [Related]
14. Application of human biomonitoring data to support policy development, raise awareness and environmental public health protection among countries within the HBM4EU project.
Ubong D; Stewart L; Sepai O; Knudsen LE; Berman T; Reynders H; Van Campenhout K; Katsonouri A; Van Nieuwenhuyse A; Ingelido AM; Castaño A; Pedraza-Díaz S; Eiríksdóttir ÁV; Thomsen C; Hartmann C; Gjorgjev D; De Felip E; Tolonen H; Santonen T; Klanova J; Norström K; Kononenko L; Silva MJ; Uhl M; Kolossa-Gehring M; Apel P; Jõemaa M; Jajcaj M; Estokova M; Luijten M; Lebret E; von Goetz N; Holcer NJ; Probst-Hensch N; Cavaleiro R; Barouki R; Tarroja E; Balčienė RM; Strumylaite L; Latvala S; Namorado S; Szigeti T; Ingi Halldorsson T; Olafsdottir K; Wasowicz W;
Int J Hyg Environ Health; 2023 Jun; 251():114170. PubMed ID: 37207539
[TBL] [Abstract][Full Text] [Related]
15. Hexamoll® DINCH and DPHP metabolites in urine of children and adolescents in Germany. Human biomonitoring results of the German Environmental Survey GerES V, 2014-2017.
Schwedler G; Conrad A; Rucic E; Koch HM; Leng G; Schulz C; Schmied-Tobies MIH; Kolossa-Gehring M
Int J Hyg Environ Health; 2020 Aug; 229():113397. PubMed ID: 31585790
[TBL] [Abstract][Full Text] [Related]
16. Substitutes mimic the exposure behaviour of REACH regulated phthalates - A review of the German HBM system on the example of plasticizers.
Lemke N; Murawski A; Lange R; Weber T; Apel P; Dębiak M; Koch HM; Kolossa-Gehring M
Int J Hyg Environ Health; 2021 Jul; 236():113780. PubMed ID: 34126298
[TBL] [Abstract][Full Text] [Related]
17. The European human biomonitoring platform - Design and implementation of a laboratory quality assurance/quality control (QA/QC) programme for selected priority chemicals.
Esteban López M; Göen T; Mol H; Nübler S; Haji-Abbas-Zarrabi K; Koch HM; Kasper-Sonnenberg M; Dvorakova D; Hajslova J; Antignac JP; Vaccher V; Elbers I; Thomsen C; Vorkamp K; Pedraza-Díaz S; Kolossa-Gehring M; Castaño A
Int J Hyg Environ Health; 2021 May; 234():113740. PubMed ID: 33774419
[TBL] [Abstract][Full Text] [Related]
18. How to use human biomonitoring in chemical risk assessment: Methodological aspects, recommendations, and lessons learned from HBM4EU.
Santonen T; Mahiout S; Alvito P; Apel P; Bessems J; Bil W; Borges T; Bose-O'Reilly S; Buekers J; Cañas Portilla AI; Calvo AC; de Alba González M; Domínguez-Morueco N; López ME; Falnoga I; Gerofke A; Caballero MDCG; Horvat M; Huuskonen P; Kadikis N; Kolossa-Gehring M; Lange R; Louro H; Martins C; Meslin M; Niemann L; Díaz SP; Plichta V; Porras SP; Rousselle C; Scholten B; Silva MJ; Šlejkovec Z; Tratnik JS; Joksić AŠ; Tarazona JV; Uhl M; Van Nieuwenhuyse A; Viegas S; Vinggaard AM; Woutersen M; Schoeters G
Int J Hyg Environ Health; 2023 Apr; 249():114139. PubMed ID: 36870229
[TBL] [Abstract][Full Text] [Related]
19. Human biomonitoring guidance values (HBM-GVs) for priority substances under the HBM4EU initiative - New values derivation for deltamethrin and cyfluthrin and overall results.
Apel P; Lamkarkach F; Lange R; Sissoko F; David M; Rousselle C; Schoeters G; Kolossa-Gehring M
Int J Hyg Environ Health; 2023 Mar; 248():114097. PubMed ID: 36577283
[TBL] [Abstract][Full Text] [Related]
20. Human biomonitoring initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) derived for bisphenol A.
Ougier E; Zeman F; Antignac JP; Rousselle C; Lange R; Kolossa-Gehring M; Apel P
Environ Int; 2021 Sep; 154():106563. PubMed ID: 33894553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
